Previous Article | Next Article 
Molecular and Cellular Biology, April 2003, p. 2351-2361, Vol. 23, No. 7
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.7.2351-2361.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Commitment Point during G0
G1 That Controls Entry into the Cell Cycle
Nicholas C. Lea,1 Stephen J. Orr,1 Kai Stoeber,2 Gareth H. Williams,2 Eric W.-F. Lam,3 Mohammad A. A. Ibrahim,4 Ghulam J. Mufti,1 and N. Shaun B. Thomas1*
Departments of Haematological Medicine,1
Clinical Immunology, Leukaemia Sciences Laboratories, Guy's, King's and St. Thomas School of Medicine, London SE5 9NU, Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT,4
,2
Cancer Research UK Labs and Section of Cancer Cell Biology, Imperial College School of Medicine at Hammersmith Hospital, London W12 0NN, United Kingdom3
Received 23 August 2002/
Returned for modification 8 October 2002/
Accepted 16 January 2003
Initiation of T-lymphocyte-mediated immune responses involves two cellular processes: entry into the cell cycle (G0
G1) for clonal proliferation and coordinated changes in surface and secreted molecules that mediate effector functions. However, a point during G0
G1 beyond which T cells are committed to enter the cell cycle has not been defined. We define here a G0
G1 commitment point that occurs 3 to 5 h after CD3 and CD28 stimulation of human CD4 or CD8 T cells. Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16INK4A during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G0. Transition through the G0
G1 commitment point is also necessary for T cells to increase in size, i.e., to enter the cellular growth cycle. However, transition through this point is not required for the induction of effector functions. These can be initiated while cells are maintained in G0 with TAT-p16INK4A. We have termed this quiescent, activated state G0(A). Our data provide proof of the principle that entry of T cells into the cell cycle and cellular growth cycles are coupled at the G0
G1 commitment point but that these processes can be uncoupled from the early expression of molecules of effector functions.
* Corresponding author. Mailing address: Department of Haematological Medicine, Leukaemia Sciences Laboratories, Guy's, King's, and St. Thomas' School of Medicine, Rayne Institute, 123 Coldharbour La., London SE5 9NU, United Kingdom. Phone: 44-20-7848-5818. Fax: 44-20-7848-5814. E-mail:
nicholas.s.thomas{at}kcl.ac.uk.
Molecular and Cellular Biology, April 2003, p. 2351-2361, Vol. 23, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.7.2351-2361.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Jirmanova, L., Sarma, D. N., Jankovic, D., Mittelstadt, P. R., Ashwell, J. D.
(2009). Genetic disruption of p38{alpha} Tyr323 phosphorylation prevents T-cell receptor-mediated p38{alpha} activation and impairs interferon-{gamma} production. Blood
113: 2229-2237
[Abstract]
[Full Text]
-
Wu, D., Meydani, S. N.
(2008). Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J. Leukoc. Biol.
84: 900-914
[Abstract]
[Full Text]
-
Arechiga, A. F., Bell, B. D., Leverrier, S., Weist, B. M., Porter, M., Wu, Z., Kanno, Y., Ramos, S. J., Ong, S. T., Siegel, R., Walsh, C. M.
(2007). A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-2. J. Immunol.
179: 5291-5300
[Abstract]
[Full Text]
-
Fosmire, S. P., Thomas, R., Jubala, C. M., Wojcieszyn, J. W., Valli, V. E. O., Getzy, D. M., Smith, T. L., Gardner, L. A., Ritt, M. G., Bell, J. S., Freeman, K. P., Greenfield, B. E., Lana, S. E., Kisseberth, W. C., Helfand, S. C., Cutter, G. R., Breen, M., Modiano, J. F.
(2007). Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma. Vet Pathol
44: 467-478
[Abstract]
[Full Text]
-
Obermann, E. C, Went, P., Tzankov, A., Pileri, S. A, Hofstaedter, F., Marienhagen, J., Stoehr, R., Dirnhofer, S.
(2007). Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase. J. Clin. Pathol.
60: 794-797
[Abstract]
[Full Text]
-
Engedal, N., Gjevik, T., Blomhoff, R., Blomhoff, H. K.
(2006). All-trans Retinoic Acid Stimulates IL-2-Mediated Proliferation of Human T Lymphocytes: Early Induction of Cyclin D3.. J. Immunol.
177: 2851-2861
[Abstract]
[Full Text]
-
Soeiro, I., Mohamedali, A., Romanska, H. M., Lea, N. C., Child, E. S., Glassford, J., Orr, S. J., Roberts, C., Naresh, K. N., Lalani, E.-N., Mann, D. J., Watson, R. J., Thomas, N. S. B., Lam, E. W.-F.
(2006). p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo.. Mol. Cell. Biol.
26: 6170-6184
[Abstract]
[Full Text]
-
Choi, H., Cho, S.-Y., Schwartz, R. H., Choi, K.
(2006). Dual Effects of Sprouty1 on TCR Signaling Depending on the Differentiation State of the T Cell. J. Immunol.
176: 6034-6045
[Abstract]
[Full Text]
-
Migliaccio, M., Alves, P. M. S., Romero, P., Rufer, N.
(2006). Distinct Mechanisms Control Human Naive and Antigen-Experienced CD8+ T Lymphocyte Proliferation. J. Immunol.
176: 2173-2182
[Abstract]
[Full Text]
-
Leibundgut, K., Schmitz, N. M.R., Hirt, A.
(2005). Catalytic Activities of G1 Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Protein in Mobilized Peripheral Blood CD34+ Hematopoietic Progenitor Cells. Stem Cells
23: 1002-1011
[Abstract]
[Full Text]
-
Munitic, I., Ryan, P. E., Ashwell, J. D.
(2005). T Cells in G1 Provide a Memory-Like Response to Secondary Stimulation. J. Immunol.
174: 4010-4018
[Abstract]
[Full Text]
-
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., Dazzi, F.
(2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood
105: 2821-2827
[Abstract]
[Full Text]
-
Migliaccio, M., Raj, K., Menzel, O., Rufer, N.
(2005). Mechanisms That Limit the In Vitro Proliferative Potential of Human CD8+ T Lymphocytes. J. Immunol.
174: 3335-3343
[Abstract]
[Full Text]
-
Milojkovic, D., Devereux, S., Westwood, N. B., Mufti, G. J., Thomas, N. S. B., Buggins, A. G. S.
(2004). Antiapoptotic Microenvironment of Acute Myeloid Leukemia. J. Immunol.
173: 6745-6752
[Abstract]
[Full Text]
-
Eward, K. L., Obermann, E. C., Shreeram, S., Loddo, M., Fanshawe, T., Williams, C., Jung, H.-I., Prevost, A. T., Blow, J. J., Stoeber, K., Williams, G. H.
(2004). DNA replication licensing in somatic and germ cells. J. Cell Sci.
117: 5875-5886
[Abstract]
[Full Text]
-
Dondi, E., Roue, G., Yuste, V. J., Susin, S. A., Pellegrini, S.
(2004). A Dual Role of IFN-{alpha} in the Balance between Proliferation and Death of Human CD4+ T Lymphocytes during Primary Response. J. Immunol.
173: 3740-3747
[Abstract]
[Full Text]
-
Dietz, A. B., Souan, L., Knutson, G. J., Bulur, P. A., Litzow, M. R., Vuk-Pavlovic, S.
(2004). Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood
104: 1094-1099
[Abstract]
[Full Text]